endogenous retroviruses upregulated in prostate cancer

A method for diagnosing prostate cancer, wherein the method comprises the step dedetectar the presence or absence of an expression product of an endogenous retrovirus HML-2 in a sample ofa patient, wherein the patient sample contains prostate cells and / or in which it is suspected that elpaciente has prostate cancer where upregulation of the expression of at least 150% compared even negative control is indicative of prostate cancer.